Comparison of potential protection conferred by three immunization strategies (protein/protein, DNA/DNA, and DNA/protein) against Brucella infection using Omp2b in BALB/c Mice
The immunogenicity and protective efficiency of the Omp2b were evaluated against Brucella infection. Omp2b immunization induces a vigorous humoral response. Omp2b DNA priming protein boosting immunization induces higher levels of Th1 responses comparing to DNA or protein alone. Omp2b DNA priming protein boosting immunizations induces protection levels compatible to RB51 and REV-1 vaccines against B. melitensis and B. abortus challenge. Omp2b could be a potential candidate for the development of new subunit vaccines against B. melitensis and B. abortus infection.